Premium
A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi‐specific mutations
Author(s) -
Al Jumah M.,
Majumdar R.,
Al Rajeh S.,
Awada A.,
Al Zaben A.,
Al Traif I.,
Al Jumah A. R.,
Rehana Z.
Publication year - 2004
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1046/j.1351-5101.2003.00729.x
Subject(s) - exon , medicine , genotype , mutation , genetics , disease , genomic dna , polymerase chain reaction , genetic testing , gene , gastroenterology , biology
Wilson disease (WD) is a hereditary disorder, with recessive transmission and genetic heterogeneity. Several mutations of ATP7B , the gene underlying WD, were reported in many ethnic groups. In this study, mutation screening in ATP7B of 56 Saudi Arabian WD patients was undertaken. The clinical data of all patients were recorded. The entire ATP7B coding sequence, including intron–exon boundaries were screened for mutation by the polymerase chain reaction (PCR)‐based mutation detection technique and DNA sequencing. Thirty‐nine patients were symptomatic at presentation and 17 subjects were pre‐symptomatic siblings of affected patients. Fourteen patients had neurological, 11 patients had mixed (hepatic and neurological), and 14 patients had hepatic presentations. Family history suggestive of WD was present in 72% of cases and 68% had consanguineous parents. Genetic analysis showed disease‐causing mutations in three exons (exons 8, 19 and 21) of the ATP7B gene in 28 patients (50%). Mutations in exons 21 (18 cases) and 19 (one case) were unique for Saudis. This large series of Saudi patients with WD has shown wide variability in the genomic substrate of WD. There is no correlation between genotype and clinical presentation.